Clinical Dementia Rating Medical Record

• Conditions: Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient; Clinical Dementia Rating (CDR) From the Analysis of Medical Record
• Interventions: Diagnostic Test: CDR assessment face-to-face

• Registration Number: NCT04763941
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

The assessment of severity of the cognitive and functional impairment is essential in the follow-up of patients with neurocognitive disorders and in the assessment of the effectiveness of therapeutics. However, the systematic assessment of the Clinical Dementia Rating (CDR) scale is limited due to the time required to complete it (approximately 45 min to 1 hour). Insofar as studies have shown correspondences between the CDR and scales measuring cognitive and neuropsychological performance, and as part of memory consultations, several functional and neuropsychological scales are systematically administered, we wish to conduct a study validating the feasibility of the CDR based on information already available in the patient's file compared to the evaluation of the CDR by the usual method (face-to-face interview in consultation).

This study should highlight the feasibility of scoring the CDR-SB from the files of patients in memory consultation, first in terms of reliability of the scores obtained compared to the standard evaluation, and on the other hand in terms of organization and duration of administration.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-01
• Primary Completion: 2020-10-01
• Study First Submitted: 2021-02-17
• Study First Submitted QC: 2021-02-17
• Study First Posted: 2021-02-21
• Status Verified: 2022-01
• Last Update Submitted: 2022-04-29
• Last Update Posted: 2022-05-02
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 144

Inclusion Criteria

• Patient who has CDR assessment in face-to-face interview during the memory consultation,
• Patient with an isolated cognitive complaint or a neurocognitive disorder
• Patient included in the MEMORA cohort

Read More

Exclusion Criteria

• Patient or caregiver who does not wish their data to be used for research purposes within the framework of the MEMORA cohort.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Memory consultation patient	CDR assessment face-to-face	The study will be conducted on the basis of the patient consulting in Memory Consultation, specifically with the information already collected in normal care and the MEMORA cohort.

Primary Outcome Measures

Name	Time	Method
CDR Sum of boxes (CDR-SB) score out of 18	The CDR-SB score is collected at the baseline.	The CDR-SB score is obtained in normal condition and on file for the same patients. The CDR-SB score makes it possible to distinguish the following classes: 0 (normal), 0.5-4 (questionable cognitive impairment), 0.5-2.5 (questionable impairment), 3-4 (very mild major TNC or very mild dementia), 4.5- 9 (mild or mild dementia), 9.5-15.5 (moderate dementia), 16-18 (severe dementia).; The patient's aptitudes are assessed in 6 different areas: 3 cognitive skills: memory, orientation and judgment, 3 acts of everyday living: participation in collective life, home occupations and hobbies, personal care.

Trial Locations

Locations (1)

Hôpital Des Charpennes; 🇫🇷 Villeurbanne, France